IceCure Medical (ICCM) Operating Income (2020 - 2026)

IceCure Medical (ICCM) has reported Operating Income for 7 consecutive years, with $4.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Income rose 30.69% year-over-year to $4.4 million in Q2 2026; TTM through Jun 2026 was $16.7 million, a 5.44% increase from a year earlier, with the FY2025 full-year figure at $15.1 million, down 3.84% from the prior year.
• Operating Income was $4.4 million for Q2 2026 at IceCure Medical, up from $4.2 million in the prior quarter.
• Over five years, Operating Income peaked at $4.5 million in Q4 2024 and troughed at $3.2 million in Q2 2024.
• A 5-year average of $4.0 million and a median of $4.1 million in 2022 frame the typical range for Operating Income.
• Across the five-year window, Operating Income jumped 270.91% in 2022 and dropped 20.9% in 2024, its largest moves.
• Over 5 years, Operating Income stood at $3.9 million in 2022, then declined by 13.15% to $3.4 million in 2023, then jumped by 32.5% to $4.5 million in 2024, then decreased by 6.83% to $4.2 million in 2025, then advanced by 4.93% to $4.4 million in 2026.
• The last three Operating Income figures came in at $4.4 million (Q2 2026), $4.2 million (Q1 2026), and $4.2 million (Q4 2025), per Business Quant data.